Vir Biotechnology Inc. (VIR), which had a lackluster reception to its initial public offering, has gained 35 percent over the last 5 trading days but is still trading below its offering price of $20 per share.
from RTT - Biotech https://ift.tt/2Tvitba
via IFTTT
No comments:
Post a Comment